Paper42657238
Cytokine-Driven Hyperinflammation in Long COVID: Mechanisms, Biomarkers, Complement Dysregulation, and Emerging Immunotherapies-A Narrative Review.
Obeagu EI. Health Sci Rep, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cytokine-Driven Hyperinflammation in Long COVID: Mechanisms, Biomarkers, Complement Dysregulation, and Emerging Immunotherapies-A Narrative Review. Papers, record 42657238. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42657238
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cytokine-Driven Hyperinflammation in Long COVID: Mechanisms, Biomarkers, Complement Dysregulation, and Emerging Immunotherapies-A Narrative Review.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34,124,322 | Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies. | Regen Ther | 2021 | https://conductscience.org/library/papers/34124322 | PubMed |
| 2 | 34,956,607 | Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm. | Interface Focus | 2022 | https://conductscience.org/library/papers/34956607 | PubMed |
| 3 | 40,110,334 | The dynamic role of soluble urokinase plasminogen activator receptor (suPAR) in monitoring coagulation dysfunction during COVID-19 progression: a review. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/40110334 | PubMed |
| 4 | 40,092,217 | Efficient Control of IL-6, CRP and Ferritin in COVID-19 Patients With Two Variants of Beta-1,3-1,6 Glucans in Combination: An Open-Label, Prospective, Randomised Clinical Trial. | Glob Adv Integr Med Health | 2025 | https://conductscience.org/library/papers/40092217 | PubMed |
| 5 | 37,427,016 | Immunohematologic Biomarkers in COVID-19: Insights into Pathogenesis, Prognosis, and Prevention. | Pathog Immun | 2023 | https://conductscience.org/library/papers/37427016 | PubMed |
| 6 | 32,412,405 | Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation. | Eur J Rheumatol | 2020 | https://conductscience.org/library/papers/32412405 | PubMed |
| 7 | 40,729,168 | COVID-19-Omics Report: From Individual Omics Approaches to Precision Medicine. | Reports (MDPI) | 2023 | https://conductscience.org/library/papers/40729168 | PubMed |
| 8 | 35,621,229 | The role of cytokines and their antagonists in the treatment of COVID-19 patients. | Rev Med Virol | 2023 | https://conductscience.org/library/papers/35621229 | PubMed |
| 9 | 39,359,765 | Impacts of COVID-19 on hemostasis: coagulation abnormalities and management perspectives. | Ann Med Surg (Lond) | 2024 | https://conductscience.org/library/papers/39359765 | PubMed |
| 10 | 36,851,766 | Hyperinflammatory Response in COVID-19: A Systematic Review. | Viruses | 2023 | https://conductscience.org/library/papers/36851766 | PubMed |
| 11 | 33,559,152 | Biomarker-Guided Individualization of Antibiotic Therapy. | Clin Pharmacol Ther | 2021 | https://conductscience.org/library/papers/33559152 | PubMed |
| 12 | 38,543,226 | Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38543226 | PubMed |
| 13 | 35,208,467 | Cytokine Storm in COVID-19: Immunopathogenesis and Therapy. | Medicina (Kaunas) | 2022 | https://conductscience.org/library/papers/35208467 | PubMed |
| 14 | 35,269,564 | COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35269564 | PubMed |
| 15 | 34,013,158 | Triggers, Timescales, and Treatments for Cytokine-Mediated Tissue Damage. | Euro Med J Innov | 2021 | https://conductscience.org/library/papers/34013158 | PubMed |
| 16 | 37,419,534 | Postacute Sequelae of SARS-CoV-2: Musculoskeletal Conditions and Pain. | Phys Med Rehabil Clin N Am | 2023 | https://conductscience.org/library/papers/37419534 | PubMed |
| 17 | 34,248,921 | Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34248921 | PubMed |
| 18 | 39,861,166 | Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/39861166 | PubMed |
| 19 | 41,112,249 | Multi-omics and machine learning identify novel biomarkers and therapeutic targets of COVID-19. | Front Immunol | 2025 | https://conductscience.org/library/papers/41112249 | PubMed |
| 20 | 38,359,836 | Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID. | Med | 2024 | https://conductscience.org/library/papers/38359836 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNG | 3,458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL1B | 3,553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| IL6 | 3,569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| TNF | 7,124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42657238
GET https://conductscience.org/api/papers/v1/42657238/references?page=2